Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.
Sun Pharmaceutical Industries or Sun Pharma is India’s leading pharmaceutical firm which is known for the production of Active Pharmaceutical Ingredients (APIs). The company is headquartered in ...
Sun Pharma Advanced Research Company Ltd share price was down by -4.05% from the previous closing price of ₹156.20. Who are peers of Sun Pharma Advanced Research Company Ltd? The peers of Sun ...
Apixaban significantly reduces stroke risk in people with subclinical atrial fibrillation and prior stroke history.
12 May, 2015 16 Mar, 2016 5:116 244 For every 116 shares held; holder is entitled to apply 5 rights shares at a premium of RS 244 14 Jul, 2011 23 Aug, 2012 1:7 66 For every 7 shares held; holder ...
Below, you’ll find a list of Baltimore Sun editorial staff, their email addresses and phone numbers. To give The Sun newsroom a general tip, email [email protected] or call 410-332-6100.
The findings reveal the distribution of ices in ... Dec. 12, 2024 — Stars similar to the Sun produce a gigantic outburst of radiation on average about once every hundred years per star.
Winnipeggers have spoken! After casting their votes, the results are in for the top five perogy spots in the city! With 15 fantastic contenders, the competition was tight, but Perogy Hotline took ...
If it hits, the explosion would be 500 times as powerful as the atomic bomb dropped on Hiroshima and have a blast radius of more than 30 miles. A poll finds that 60 percent of Israeli Jews support ...
Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category. Citeline provides intelligence ...
On the previous day, Sun Pharma's stock closed at Rs 1,749.80, with no change in percentage, and a trading volume of 1,371,545 shares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results